SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-071472
Filing Date
2024-03-19
Accepted
2024-03-19 17:06:35
Documents
5
Effectiveness Date
2024-03-19

Document Format Files

Seq Description Document Type Size
1 S-8 d784396ds8.htm S-8 45543
2 EX-5.1 d784396dex51.htm EX-5.1 10495
3 EX-23.2 d784396dex232.htm EX-23.2 1639
4 EX-FILING FEES d784396dexfilingfees.htm EX-FILING FEES 21364
5 GRAPHIC g784396g0318192356930.jpg GRAPHIC 2658
  Complete submission text file 0001193125-24-071472.txt   84137
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 415-798-8589
Tempest Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-278071 | Film No.: 24764826
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)